Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125634032 | 12563403 | 2 | F | 20160709 | 20160714 | 20160715 | 20160721 | EXP | US-UNITED THERAPEUTICS-UNT-2016-011228 | UNITED THERAPEUTICS | 61.02 | YR | M | Y | 101.59000 | KG | 20160721 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125634032 | 12563403 | 1 | PS | REMODULIN | TREPROSTINIL | 1 | Subcutaneous | 0.0024 ?G/KG, CONTINUING | 21272 | INJECTION | |||||||||
125634032 | 12563403 | 2 | SS | ADCIRCA | TADALAFIL | 1 | 20 MG, UNK | U | U | 0 | 20 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125634032 | 12563403 | 1 | Pulmonary hypertension |
125634032 | 12563403 | 2 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125634032 | 12563403 | DE |
125634032 | 12563403 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125634032 | 12563403 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |